Evidence map›Paper›PMID 41398159›Full record

ArticleNature communications2025

Persistent pneumococcal colonisation in antiretroviral-treated HIV infection is associated with nasal inflammation.

Joseph Aston Phiri, Lusako Lucky Sibale, Gloria Kapira, Lukerensia Mlogoti, James Tchado Nyirenda, Ndaona Mitole, Alice Kusakala, Charles Ndovi, Precious Chigamba, Aaron Pearson Chirambo and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Joseph Aston PhiriMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi. jphiri@mlw.mw.
Lusako Lucky SibaleMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.ORCID http://orcid.org/0000-0001-5378-3561
Gloria KapiraMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Lukerensia MlogotiMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
James Tchado NyirendaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Ndaona MitoleMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Alice KusakalaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Charles NdoviMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Precious ChigambaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.ORCID http://orcid.org/0009-0005-6337-2850
Aaron Pearson ChiramboMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Klara DohertyMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Robert K NyirendaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Thokozani KayembeMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Janet ZambeziMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Edwin LisimbaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Memory Nekati MvulaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
David Viyezgo MhangoMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Leonard MvayaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Stephen B GordonMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.ORCID http://orcid.org/0000-0001-6576-1116
Benjamin KumwendaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Christopher MoxonMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Daniela M FerreiraMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.ORCID http://orcid.org/0000-0002-0594-0902
Henry C MwandumbaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Kondwani C JamboMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi. kjambo@mlw.mw.ORCID http://orcid.org/0000-0002-3195-2210

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite systemic viral suppression, people living with HIV (PLHIV) on antiretroviral therapy (ART) remain highly susceptible to pneumococcal colonisation and disease. Here, we show that long-term ART does not restore nasal mucosal immunity. Using flow cytometry, single-cell transcriptomics, and neutrophil functional assays, we identify a persistent mucosal immune signature in PLHIV-ART > 1 yr marked by epithelial-driven neutrophilic inflammation, T cell exhaustion, and cellular senescence. Neutrophils exhibit mitochondrial stress, senescence-associated secretory phenotype (SASP) gene expression, and impaired oxidative burst, particularly in individuals with pneumococcal carriage. Epithelial cells express elevated neutrophil-recruiting ligand genes, while nasal T cells display pro-apoptotic and exhaustion gene profiles. Neutrophilic inflammation is strongly associated with pneumococcal carriage density, implicating a feedforward loop between inflammation and microbial persistence. Our findings reveal tissue-specific immune dysregulation despite ART and suggest that targeting epithelial-immune signalling or neutrophil senescence may offer novel therapeutic avenues to reduce respiratory pathogen burden in PLHIV.

Indexed as

HIV InfectionsNasal MucosaPneumococcal InfectionsStreptococcus pneumoniaeAdultCellular SenescenceEpithelial CellsFemaleHumansInflammationMaleMiddle AgedNeutrophilsT-Lymphocytes

Identifiers

PMID41398159
PMCPMC12808677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.